* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download XIANG Hua
Molecular cloning wikipedia , lookup
Protein moonlighting wikipedia , lookup
Genome (book) wikipedia , lookup
Biology and consumer behaviour wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Genome evolution wikipedia , lookup
DNA vaccination wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Gene nomenclature wikipedia , lookup
Epigenetics of diabetes Type 2 wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Genetic engineering wikipedia , lookup
Genomic library wikipedia , lookup
Point mutation wikipedia , lookup
Designer baby wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Gene expression programming wikipedia , lookup
Helitron (biology) wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Microevolution wikipedia , lookup
Gene expression profiling wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
History of genetic engineering wikipedia , lookup
No-SCAR (Scarless Cas9 Assisted Recombineering) Genome Editing wikipedia , lookup
Research Overview of the group of Molecular Genetics of Extremely Halophilic Archaea Prof. Dr. Hua Xiang Part I. Introduction The research group for Molecular Genetics of Extremely Halophilic Archaea (haloarchaea), led by Dr. Hua Xiang, focuses on the genetics of haloarchaea, with several plasmids and halocins as models for the research of a variety of fundamental processes in archaea, such as DNA replication, transcriptional regulation, protein processing/translocation, and signal transduction. This group is also interested in the biotechnology in thermophilic bacteria, food-grade lactic acid bacteria, as well as halophilic archaea. A few genetic tools and biotechnological application were achieved. Dr. Xiang received his B.S. and M.S. from Beijing Normal University, and earned his Ph.D. in Biochemistry & Molecular biology in 1997 from the Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS&PUMC). He was a postdoctoral fellow in Institute of Microbiology, Chinese Academy of Sciences from 1997 to 1999, and held another postdoctoral position from 1999 to 2001 in the Department of Molecular Biology, University of Medicine & Dentistry of New Jersey (UMDNJ), in USA. He established this research group in 2001 after he came back to this Institute. Currently, this research group has grown to become a creative team with 12 young people, including 1 senior technician, 2 assistant professors, 1 postdoc and 7 graduate students. Part II. Background and Significance Archaea have been recognized as the third life domain in this planet since the late 1970s. They are biochemically and genetically different from the other two domains, Bacteria and Eukaryota. Many archaea thrive in extremely harsh conditions,such as boiling water or super-salty pools, etc. These types of archaea are often labeled "extremophiles," meaning creatures that love extreme conditions. The extremely halophilic archaea require external concentrations of 2 to 4.5 M NaCl for optimal growth, which indeed represent the salinity limit that an earth life can endure. Haloarchaea are easy to culture and are genetically tractable, hence they are an excellent model for archaeal genetics. Furthermore, these extremophiles also have considerable biotechnological potentials. They possess unique bacteriorhodopsin, extreme enzymes, liposomes, biopolymers and many other substances with application potentials. The achievements in genetics and biotechnology would help us to comprehensively understand these halophiles and effectively utilize these special microbial resources. Part III. Major Achievements 1. Molecular genetics and biotechnology of haloarchaeal plasmids A novel rolling-circle (RC) replicating plasmid pNB101 (2,538 bp) isolated from Natronobacterium sp. strain AS7091 has been completely sequenced. It is the first plasmid isolated from a haloalkaliphilic archaeon. The putative double-stranded origin (DSO), single-stranded origin (SSO), as well as the rep gene were identified, and the single-stranded DNA intermediate that corresponds to the leading strand in RC replication was experimentally demonstrated. A high-level transcription of DSO was observed and supposed to be involved in the initiation of this RC replication (Extremophiles, 2004, 8: 81-89). With insertion of the Escherichia coli ColE1 replicon and two antibiotic resistance genes into this plasmid, a novel shuttle vector (pNB102) between haloarchaea and E.coli was developed. pNB102 was successfully transformed into two non-haloalkaliphilic archaea, Halobacterium salinarum and Haloarcula hispanica. It is the first report that the replicon of pNB101 has such a wide host range, and has taken the first step for construction of the first vector/host system in haloalkaliphilic archaea (Biotechnol Lett 2004, 26: 1107-1113). This haloarchaeal vector was patented in P. R. China, and was successfully used to optimize the bacteriorhodopsin in H. salinarum (Patent No. ZL02100714.4 and No. 200510087721.1). Recently, we have completely sequenced another novel plasmid pSCM201 (3463 bp), which was isolated from Haloarcula sp. AS7094. This plasmid seems to be unique as no homology was found with all other reported plasmids. By means of 2D agarose gel electrophoresis and electron microscopy analysis, the pSCM201 was demonstrated to be a unidirectional theta-replicating plasmid. To our knowledge, it is the smallest theta plasmid observed so far in archaea. With this replicon, several highly stable vectors were developed and successfully transformed into Haloarcula hispanica, which was also applied for a Chinese patent. Moreover, the minimal replicon (1.8kb) containing only the putative origin and the replication initiation gene was determined by gradual deletion of the plasmid sequence. Currently, we are mapping the precise point of the replication initiation within the putative origin, and determining the elements that might be involved in the replication initiation. Since the in vivo analysis system has been established, it would be a good model for study haloarchaeal DNA replication, and the paper will be prepared for publication in the journal Nucleic Acids Research in near future. In the meantime, we have also completely sequenced two other novel haloarchaeal plasmids pZMX101 (3918 bp) and pZMX201 (1668 bp). Sequence analysis indicates that pZMX101 is very possible to be a theta-replicating plasmid, while pZMX201 will be the smallest RC-replicating plasmid so far isolated in halophilic archaea. 2. Molecular biology of the haloarchaeal peptide antibiotics (halocins) Halocins are bacteriocin-like proteins or peptides produced by many species of the family Halobacteriaceae. HalC8, a novel halocin isolated from Halobacterium strain AS7092, is an extremely stable and hydrophobic microhalocin with a wide inhibitory spectrum against the haloarchaea. Its primary target was found to be located in the cell wall of the sensitive cells. HalC8 can be desalted, frozen, subjected to many organic solvents, and boiled for about one hour without losing activity. It was purified by combination of tangential flow filtration (TFF), Sephadex G50 and DEAE-sepharose chromatography, and the N-terminal amino acid sequence was determined by Edman degradation (Extremophiles, 2003, 7: 401-7). According to the N-terminal amino acid sequence of HalC8, the encoding gene for this halocin was cloned recently, which strongly supports that HalC8 is derived from the C-terminus of a 283-amino-acid prepro-protein (ProC8). This was further verified by MALDI-TOF-MS analysis of the purified HalC8. The production of HalC8 was controlled through both transcriptional regulation and protein processing: the halC8 transcripts and HalC8 activity rapidly increased to maximal levels upon transition from exponential to stationary phase. However, while halC8 transcripts remained abundant, the HalC8 processing was inhibited during stationary phase. Remarkably, agar-diffusion test revealed the unprocessed ProC8 and its 207-amino-acid N-terminal peptide (HalI), with or without its putative Tat signal sequence, were capable to block the halocin activity of HalC8 in vitro. In addition, heterologous expression of HalI in Haloarcula hispanica rendered this sensitive strain remarkable resistance to HalC8, indicating that HalI encodes the immunity property of the producer. In accordance with this immunity function, HalI and ProC8 were both found localized on the cellular membrane. Protein interaction assay revealed that HalI likely sequestrated the HalC8 activity by specific binding. To our knowledge, this is the first report on halocin immunity, and our results that a single gene encodes both peptide antibiotic and immunity protein also provide a novel immune mechanism for peptide antibiotics (Mol Microbiol, 2005, 57: 537-549). Currently, a 9.3-kb gene cluster containing the halocin C8 gene and six other genes was cloned and sequenced. The novel genes encode a putative regulator and several transporters, which were speculated to be involved in the halocin expression regulation and transportation. It would provide a novel and great opportunity for halocin research in the future. 3. Thermoanaerobacter tengcongensis: genetics and bioengineering T. tengcongensis is a thermophilic bacterium isolated in Tengcong hot springs in the south of China, and is the first bacterium whose genome was completely sequenced in this country. Our group has taken part in partial works to understand its fundamental genetics and several biotechnological potential genes. As the genetic tools were still not established for this bacterium, we mainly investigated the DnaA-based replication initiation and ECF-sigma factor-involved/stress-induced gene expression regulation by protein-protein interaction assay and other biochemical techniques, hoping to reveal novel factors or novel mechanisms in these fundamental processes in this thermophile, especially to understand parts of those uncharacterized genes in this genome. In respect of the bioengineering of genes in this thermophile, a thermostable esterase from this bacterium has been cloned, over-expressed, and biochemically characterized (Biotechnol Lett, 2003, 25: 1463-1467). We have also identified a novel trehalose synthesis pathway in this bacterium, where the dominant function of the T. tengcongensis trehalose phosphorylase (TreP) was proved to catalyze trehalose synthesis but not degradation. A new approach for production of trehalose from starch with the thermostable T. tengcongensis enzymes was also proposed (Science in China-C , 2005, 48: 221-227). 4. Biotechnology in Lactococcus lactis L. lactis has been safely used in the food industry for centuries and is considered as potential mucosal delivery vehicles of vaccine antigens. In cooperation with Prof. Huarong Tan’s group, we have established a novel food-grade gene expression system in Lactococcus lactis. The food-grade expression of human glutathione S-transferase (hGST) and Cu/Zn superoxide dismutase (hSOD) in L. lactis and their high-level expression in E.coli were achieved (Biotechnol Lett, 2002, 24:1669-1672; Biomol Eng, 2003, 20: 107-112), and the hSOD biotechniques have been transfer to a company with 3.2 million RMB Yuan. Recently, we have also expressed the SARS-coronavirus nucleocapsid (N) protein in E. coli for serodiagnosis and in L. lactis for mucosal vaccination. Results indicated that orally delivered SARS-N-producing L. lactis could induce significant N-specific IgG in the sera (Appl Microbiol Biotechnol 2005, 68: 220-227). Publication (SCI journal only) list: 1. Sun C,Li Y, Mei S, Lu Q, Zhou L, Xiang H*. 2005. A single gene directs both production and immunity of halocin C8 in a haloarchaeal strain AS7092. Molecular Microbiology 57 (2):537–549. 2. Pei H, Liu J, Cheng Y, Sun C, Wang C, Lu Y, Ding J, Zhou J, Xiang H* . 2005, Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination. Appl Microbiol Biotechnol 68: 220–227. 3. Ren Y, Dai X, Zhou J, Liu J, Pei H, Xiang H*. 2005. Gene Expression and molecular characterization of thermostable trehalose phosphorylase in Thermoanaerobacter tengcongensis . Sci China (Ser C) 48(3): 221-227. 4. Zhou M, Xiang H*, Sun C, Tan H. 2004. Construction of a novel shuttle vector based on an RCR-plasmid from a haloalkaliphilic archaeon and transformation into other haloarchaea. Biotechnol Lett 26: 1107-1113. 5. Zhou M, Xiang H*, Sun C, Li Y, Liu J, Tan H. 2004. Complete sequence and molecular characterization of pNB101, a rolling-circle replicating plasmid from the haloalkaliphilic archaeon Natronobacterium sp. strain AS7091. Extremophiles 8(2): 81-89. 6. Li Y, Xiang H*, Liu J, Zhou M, Tan H. 2003. Purification and biological characterization of halocin C8, a novel peptide antibiotic from Halobacterium strain AS7092. Extremophiles 7(5): 401-7. 7. Xiang H , Wei W, Tan H*. 2003. Food-grade expression of human glutathione S-transferase and Cu/Zn superoxide dismutase in Lactococcus lactis. Biomol Eng 20(3): 107-112. 8. Zhang J, Liu J, Zhou J, Ren Y, Dai X, Xiang H*. 2003. Thermostable esterase from Thermoanaerobacter tengcongensis: high-level expression, purification and characterization. Biotechnol Lett 25: 1463-1467. 9. Wei W, Xiang H*, Tan H*. 2002.Two tandem promoters to increase gene expression in Lactococcus lactis. Biotechnol Lett, 24:1669-1672. * Corresponding author Patent list: 1. Hua Xiang, Meixian Zhou and Huarong Tan. 2002, One haloalkaliphilic archaeal strain and its plasmid, and their application (granted in 2004 with granted patent No. ZL02100714.4). 2. Hua Xiang, Jian Zhang, Jian Zhou, Yuqing Tian and Huarong Tan. 2003. The application of a thermostable lipase and its bioengineering bacteria (Application No.03136565.5). 3. Hua Xiang, Chaoming Sun. 2004. A haloarchaeal plasmid and its derived plasmid vectors (Application No. 2004100497519). 4. Hua Xiang, Yuanyuan Ren, Jingfang Liu, Jian Zhou, Huarong Tan. 2004. The gene encoding a novel thermostable trehalose synthase and its application (Application No. 200410073883.5). 5. Hua Xiang, Yun Li, Chaoming Sun. 2005. The genes encoding a halocin and its immunity protein and their application (Application No. 200510055640.3) 6. Hua Xiang, Ligang Zhou, Meixian Zhou, Chaoming Sun, Jian Zhou. 2005. A plasmid for expression of bacteriorhodopsin mutants in haloarchaea and their bioengineering archaea. (Application No. 200510087721.1) Part IV. Future Research Plan The future research of this group will focus on the genetics and bioengineering of halophilic archaea. We will use the halocins and the haloarchaeal plasmids as models to further explore the fundamental processes of halophilic archaea in replication, transcriptional regulation, protein processing, protein translocation, and signal transduction, etc. We will also establish novel haloarchaeal gene expression systems for bioengineering of bacteriorhodopsin, biopolymers, halophilic enzymes as well as halocins in halophilic archaea. Moreover, to better understand the differences between archaea and bacteria, we will also investigate the mechanisms of DNA replication and gene expression regulation in T. tengcongensis. Our work will provide the fundamental information and biotechnological potential of these extremophiles.